Boehringer Ingelheim has selected Certara’s D360 as its global drug discovery platform. D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data. It will allow Boehringer to share discovery data across global working groups, including external collaborators. Boehringer plans to install the global data mining tool at three sites, Ridgefield, CT, Biberach, Germany, and Vienna, Austria.
“In addition to integrating data for easy access, D360 empowers researchers to query and analyze their data without support from the IT team,” said Jonathan Feldmann, vice president of scientific informatics at Certara. “D360 enables researchers to quickly answer their questions as they conceive them, thus helping to shorten the drug discovery cycle.”
Boehringer Selects Certara’s Drug Discovery Platform
Published October 17, 2013
blog comments powered by Disqus